Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diabetes Testing Results Remotely Managed and Monitored

By LabMedica International staff writers
Posted on 28 Sep 2011
Point-of-care (POC) coordinators and laboratory managers can remotely monitor and manage HbA1c and microalbumin testing results using expanded data management solution connectivity.

The new RAPIDComm system is accessible from any computer connected to the hospital-wide network and can be customized to address the needs of different departments, users, and patients. More...
With this system, POC coordinators are able to remotely manage and maximize instrument uptime, simplify instrument control, and operator management.

Siemens Healthcare Diagnostics (Tarrytown, NY, USA) launched the RAPIDComm new data management solution Version 4.0, extending system connectivity to the company’s DCA Vantage diabetes analyzer. The data management system also enhances quality control (QC) management and documentation with automated QC result processing and customizable regulatory reports.

Now point-of-care (POC) laboratory managers are able to rely on a single, advanced user interface to remotely monitor and manage diabetes-testing results, in addition to blood gas via RAPIDSystems, and urinalysis via the CLINITEK Status Connect System. This move further integrates patient data throughout the healthcare network.

With decentralized testing, POC coordinators may be responsible for monitoring large numbers of instruments spread throughout a hospital or various hospital sites, which are operated by several hundred to several thousand operators.

“Healthcare professionals that manage POC testing in hospitals, clinics, and physician offices are increasingly looking to integrate their instruments with a data management solution to reduce transcription errors and better manage data, quality control, and operators, which ultimately helps to improve patient care,” said David Stein, PhD, CEO, Point of Care Business Unit, Siemens Healthcare Diagnostics. “A key priority for Siemens is to continue the innovation of our instruments and data management solutions to provide our POC customers with innovative and flexible connectivity options.”

Related Links:
Siemens Healthcare Diagnostics



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.